Expanding the ADC Target Landscape Through Multimodal Data-Informed Tumor Tissue Proteomics
- Identifying high confidence novel targets via innovative proteomic platforms
- Explaining modality-agnostic strategies to validate ADC targets across indications
- Validating the patient landscape through clinico- genomic and wet lab insights